Cancer Mortality Projections in Korea up to 2032
- PMID: 27247498
- PMCID: PMC4853668
- DOI: 10.3346/jkms.2016.31.6.892
Cancer Mortality Projections in Korea up to 2032
Abstract
Predicting cancer mortality is important to estimate the needs of cancer-related services and to prevent cancer. Despite its significance, a long-term future projection of cancer mortality has not been conducted; therefore, our objective was to estimate future cancer mortality in Korea by cancer site through 2032. The specially designed Nordpred software was used to estimate cancer mortality. The cancer death data from 1983 to 2012 and the population projection data from 1983 to 2032 were obtained from the Korean National Statistics Office. Based on our analysis, age-standardized rates with the world standard population of all cancer deaths were estimated to decline from 2008-2012 to 2028-2032 (men: -39.8%, women: -33.1%). However, the crude rates are predicted to rise (men: 29.8%, women: 24.4%), and the overall number of the cancer deaths is also estimated to increase (men: 35.5%, women: 32.3%). Several cancer deaths are projected to increase (lung, liver and gallbladder, colon and rectum, pancreas and leukemia in both sexes; prostate cancer in men; and breast and ovarian cancer in women), whereas other cancer deaths are expected to decrease (stomach, esophagus and larynx in both sexes and cervical cancer in women). The largest contribution to increasing cancer deaths is due to the aging of the Korean population. In conclusion, a strategy for primary prevention, early detection, and early treatment to cope with the rapidly increasing death of cancer due to population aging is urgently required.
Keywords: Korea; Mortality Forecasting; Neoplasms.
Conflict of interest statement
Figures



Similar articles
-
Forecasting Cause-Specific Mortality in Korea up to Year 2032.J Korean Med Sci. 2016 Aug;31(8):1181-9. doi: 10.3346/jkms.2016.31.8.1181. Epub 2016 May 30. J Korean Med Sci. 2016. PMID: 27478326 Free PMC article.
-
Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis.Asian Pac J Cancer Prev. 2010;11(6):1451-7. Asian Pac J Cancer Prev. 2010. PMID: 21338179
-
Projected mortality from lung cancer in South Korea, 1980-2004.Int J Epidemiol. 1998 Jun;27(3):365-9. doi: 10.1093/ije/27.3.365. Int J Epidemiol. 1998. PMID: 9698121
-
Epidemiology of cancer in the United States.Prim Care. 1992 Sep;19(3):419-41. Prim Care. 1992. PMID: 1410056 Review.
-
Updates on Cancer Epidemiology in Korea, 2018.Chonnam Med J. 2018 May;54(2):90-100. doi: 10.4068/cmj.2018.54.2.90. Epub 2018 May 25. Chonnam Med J. 2018. PMID: 29854674 Free PMC article. Review.
Cited by
-
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.PLoS One. 2017 Aug 17;12(8):e0183404. doi: 10.1371/journal.pone.0183404. eCollection 2017. PLoS One. 2017. PMID: 28817672 Free PMC article.
-
Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients.BioDrugs. 2021 Jan;35(1):61-73. doi: 10.1007/s40259-020-00459-2. Epub 2020 Dec 17. BioDrugs. 2021. PMID: 33331991
-
Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries.Papillomavirus Res. 2017 Jun;3:126-133. doi: 10.1016/j.pvr.2017.04.001. Epub 2017 Apr 6. Papillomavirus Res. 2017. PMID: 28720446 Free PMC article.
-
Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer.J Korean Med Sci. 2023 Nov 20;38(45):e381. doi: 10.3346/jkms.2023.38.e381. J Korean Med Sci. 2023. PMID: 37987107 Free PMC article.
-
Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K).J Korean Med Sci. 2016 Dec;31(12):1969-1975. doi: 10.3346/jkms.2016.31.12.1969. J Korean Med Sci. 2016. PMID: 27822937 Free PMC article.
References
-
- Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev. 2002;11(Suppl 1):S1–96. - PubMed
-
- Møller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, Haldorsen T. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22:2751–2766. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources